{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:21:52Z","timestamp":1788852112798,"version":"build-2803163510"},"reference-count":67,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2023\/49\/N\/NZ7\/01039"],"award-info":[{"award-number":["2023\/49\/N\/NZ7\/01039"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Applied Toxicology"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In silico techniques, such as physiologically based pharmacokinetic modeling (PBKP), are recently gaining importance. Computational methods in drug discovery and development and the generic drugs industry enhance research effectiveness by saving time and money and avoiding ethical issues. One key advantage is the ability to conduct toxicology studies without risking harm to living beings. This study aimed to repurpose the multi\u2010phase multi\u2010layer mechanistic dermal absorption (MPML MechDermA) PBPK model for simulation permeation through porcine ear skin under in vitro conditions. The work was divided into four steps: (1) the development of a pig ear skin model based on a previously collected dataset; (2) testing the model's ability to discriminate permeation between pig ear, human abdomen, and human back skin; (3) development of a caffeine permeation model; and (4) testing the caffeine model's performance against in vitro generated data sourced from the scientific literature. Data from 31 manuscripts were used for the development of the pig skin model. Based on these data, values specific to pig skin were found for 22 parameters of the MPML MechDermA model. The model was able to discriminate permeation between pig and human skin. A caffeine model was developed and used to simulate seven experiments identified in the literature. The model's performance was assessed by comparing simulated to observed results. Based on a visual check, all simulations were considered acceptable, whereas three out of seven experiments met the twofold difference criterion. The variability of the experimental data was considered the biggest challenge for reliable model assessment.<\/jats:p>","DOI":"10.1002\/jat.4687","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T21:13:32Z","timestamp":1723497212000},"page":"1936-1948","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Physiologically\u2010based pharmacokinetic model of in vitro porcine ear skin permeation for drug delivery research"],"prefix":"10.1002","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6541-435X","authenticated-orcid":false,"given":"Laura","family":"Krumpholz","sequence":"first","affiliation":[{"name":"Pharmacoepidemiology and Pharmacoeconomics Unit, Faculty of Pharmacy Jagiellonian University Medical College  Krak\u00f3w Poland"},{"name":"Doctoral School in Medical and Health Sciences Jagiellonian University Medical College  Krak\u00f3w Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Polak","sequence":"additional","affiliation":[{"name":"Chair of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy Jagiellonian University Medical College  Krak\u00f3w Poland"},{"name":"Certara UK Ltd. (Simcyp Division)  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wi\u015bniowska","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Pharmacoeconomics Unit, Faculty of Pharmacy Jagiellonian University Medical College  Krak\u00f3w Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S64788"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12825"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbz103"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081554"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12020173"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2008.10.008"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000441038"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2008.03.003"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.201700355"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1007496"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2013.2060"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1992.tb05485.x"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.2903\/sp.efsa.2017.EN-1250"},{"key":"e_1_2_11_15_1","unstructured":"European Medicines Agency. (2018).Draft guideline on quality and quivalence of topical products."},{"key":"e_1_2_11_16_1","unstructured":"Food and Drug Administration. (2022).In vitro permeation test studies for topical drug products submitted in ANDAs guidance for industry. Draft guidance."},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.07.004"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)34493-X"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.036103"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1984.tb04363.x"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9011-8"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104752"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0846.2006.00179.x"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/js960198e"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3004"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ahe.12425"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13165"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baac091"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.816284"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00480-4"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324884"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-022-03274-2"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2023.06.004"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.05.050"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.03.043"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/srt.12098"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2022.08.005"},{"issue":"5","key":"e_1_2_11_38_1","first-page":"499","article-title":"Comparison of bovine udder skin with human and porcine skin in percutaneous permeation experiments","volume":"34","author":"Netzlaff F.","year":"2006","journal-title":"Alternatives to Laboratory Animals: ATLA"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-52"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1159\/000135638"},{"key":"e_1_2_11_41_1","doi-asserted-by":"crossref","unstructured":"OECD. (2004).Test No. 428: Skin absorption: In vitro method. OECD.https:\/\/doi.org\/10.1787\/9789264071087-en","DOI":"10.1787\/9789264071087-en"},{"key":"e_1_2_11_42_1","unstructured":"OECD. (2019).Guidance notes on dermal absorption."},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/2168479019875338"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12814"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.slast.2021.12.006"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpph.79"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600800203"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/026119290603400312"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205458"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rinphs.2014.09.002"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000036912.94452.d0"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104851"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1013"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1159\/000029928"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1081\/DCT-100108474"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802103-3.00002-X"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.03.024"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.05.040"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9030033"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12600"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40495-016-0060-3"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43188-023-00185-1"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2007.12.027"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106324"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1117\/1.3103340"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116357"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.895556"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01045-7"}],"container-title":["Journal of Applied Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jat.4687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:35:28Z","timestamp":1760517328000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/jat.4687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1002\/jat.4687"],"URL":"https:\/\/doi.org\/10.1002\/jat.4687","archive":["Portico"],"relation":{},"ISSN":["0260-437X","1099-1263"],"issn-type":[{"value":"0260-437X","type":"print"},{"value":"1099-1263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"2024-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}